Avenue Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Avenue Therapeutics

16/08/2021 18:29

* Avenue Therapeutics Inc  ATXI.OQ  reported a quarterly
adjusted loss of 6 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 6 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Avenue Therapeutics Inc's reported EPS for the quarter was a
loss of 6 cents​.
* The mean earnings estimate of analysts had risen by about 7.7%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Avenue Therapeutics Inc shares had fallen by 31.9% this
quarter and lost 71.3% so far this year.
* The company reported a quarterly loss of $949 thousand.
* Wall Street's median 12-month price target for Avenue
Therapeutics Inc is $12.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 05:29 p.m.  ​All
figures in US dollars unless otherwise stated